Author

Federica Riccardo

Observed names: F Riccardo, F. Riccardo, Riccardo, Federica

Institution: University of Turin

Observed institution: University of Turin

ORCID: 0000-0002-9692-0172

Observed ORCID: 0000-0002-9692-0172

OpenAlex ID: A5078282084

CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA

2014 · Federica Riccardo, Selina Iussich, et al. · Clinical Cancer Research · 80

CSPG4: a prototype oncoantigen for translational immunotherapy studies

2017 · Valeria Rolih, Giuseppina Barutello, et al. · Journal of Translational Medicine · 74

PDF

Cancer vaccines: Target antigens, vaccine platforms and preclinical models

2024 · Francesca Ruzzi, Federica Riccardo, et al. · Molecular Aspects of Medicine · 71

Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences

2017 · A Valentino, A Calarco, et al. · Oncogene · 68

Novel insights into Notum and glypicans regulation in colorectal cancer

2015 · Mariangela De Robertis, Maddalena Arigoni, et al. · Oncotarget · 64

PDF

Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: description of the diverse and most represented species

2017 · Giulio Ferrero, Francesca Cordero, et al. · Oncotarget · 63

PDF

miR-135b Coordinates Progression of ErbB2-Driven Mammary Carcinomas through Suppression of MID1 and MTCH2

2013 · Maddalena Arigoni, Giuseppina Barutello, et al. · American Journal Of Pathology · 62

PDF

Prolongation of survival of dogs with oral malignant melanoma treated byen blocsurgical resection and adjuvant CSPG4 ‐antigen electrovaccination

2016 · L. A. Piras, F. Riccardo, et al. · Veterinary and Comparative Oncology · 61

Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy

2019 · Lidia Tarone, Giuseppina Barutello, et al. · Cancer Immunology Immunotherapy · 59

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter

2018 · Roberto Ruiu, Valeria Rolih, et al. · Cancer Immunology Immunotherapy · 52

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy

2018 · Giuseppina Barutello, Valeria Rolih, et al. · International Journal of Molecular Sciences · 51

PDF

Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source

2019 · Roberto Ruiu, Lidia Tarone, et al. · Progress in molecular biology and translational science · 50

Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2020 · Laura Conti, Elisabetta Bolli, et al. · Cancer Immunology Research · 48

PDF

The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis

2016 · Silvio Bandini, Marco Macagno, et al. · OncoImmunology · 46

PDF

The importance of comparative oncology in translational medicine

2014 · Federica Riccardo, Luigi Aurisicchio, et al. · Cancer Immunology Immunotherapy · 43

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy

2022 · Antonino Di Lorenzo, Elisabetta Bolli, et al. · OncoImmunology · 39

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer

2020 · Valeria Rolih, Jerri Caldeira, et al. · Cancers · 39

PDF

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

2014 · Federica Riccardo, Maddalena Arigoni, et al. · BMC Genomics · 39

PDF

Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy

2021 · Giulia Peppino, Roberto Ruiu, et al. · International Journal of Molecular Sciences · 38

PDF

HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer

2022 · Junbiao Wang, Alessia Lamolinara, et al. · Cancers · 36

PDF

Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis

2018 · Lucia Coscujuela Tarrero, Giulio Ferrero, et al. · Oncotarget · 34

PDF

Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases

2021 · Davide Giacobino, Mariateresa Camerino, et al. · Veterinary and Comparative Oncology · 33

Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma

2019 · Federica Riccardo, Lidia Tarone, et al. · Therapeutic Advances in Medical Oncology · 33

PDF

Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance

2014 · Federica Riccardo, Elisabetta Bolli, et al. · Current topics in microbiology and immunology · 28

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

2011 · Elena Quaglino, Federica Riccardo, et al. · Cancers · 27

PDF

Works count: 92

Citation count: 1,510

H-index: 26

I10-index: 37